000 | 01823 a2200589 4500 | ||
---|---|---|---|
005 | 20250518021109.0 | ||
264 | 0 | _c20200603 | |
008 | 202006s 0 0 eng d | ||
022 | _a1468-6244 | ||
024 | 7 |
_a10.1136/jmedgenet-2018-105792 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorgan, Robert D | |
245 | 0 | 0 |
_aPrevalence of germline pathogenic _h[electronic resource] |
260 |
_bJournal of medical genetics _c05 2019 |
||
300 |
_a301-307 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 |
_aCarcinoma, Ovarian Epithelial _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Association Studies |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aGenetic Testing |
650 | 0 | 4 | _aGerm-Line Mutation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 |
_aOvarian Neoplasms _xdiagnosis |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBurghel, George J | |
700 | 1 | _aFlaum, Nicola | |
700 | 1 | _aBulman, Michael | |
700 | 1 | _aClamp, Andrew R | |
700 | 1 | _aHasan, Jurjees | |
700 | 1 | _aMitchell, Claire L | |
700 | 1 | _aSchlecht, Helene | |
700 | 1 | _aWoodward, Emma R | |
700 | 1 | _aLallo, Fiona I | |
700 | 1 | _aCrosbie, Emma J | |
700 | 1 | _aEdmondson, Richard J | |
700 | 1 | _aWallace, Andrew J | |
700 | 1 | _aJayson, Gordon C | |
700 | 1 | _aEvans, D Gareth R | |
773 | 0 |
_tJournal of medical genetics _gvol. 56 _gno. 5 _gp. 301-307 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/jmedgenet-2018-105792 _zAvailable from publisher's website |
999 |
_c29293997 _d29293997 |